![Catherine Moukheibir](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Catherine Moukheibir
Directeur/Membre du Conseil chez
MOONLAKE IMMUNOTHERAPEUTICS
Fortune : 635 118 $ au 31/05/2026
Profil
Catherine Moukheibir is currently Independent Director at Ironwood Pharmaceuticals, Inc. since 2019; Director at Asceneuron SA since 2021; Director at Esteve Healthcare SL; Director at CMR Surgical Ltd. since 2021; Independent Director at DNA Script SAS since 2021; Independent Director at Noema Pharma AG since 2021; Director at Moonlake Immunotherapeutics AG; and Independent Director at MoonLake Immunotherapeutics since 2022.
Former roles include Chairman & Chief Executive Officer at MedDay Pharmaceuticals SA from 2019 to 2021; Chairman at Creabilis Therapeutics Srl; Chairman at Creabilis Holdings Ltd. from 2015 to 2016; Executive Director-Investment Banking at Morgan Stanley in 2000; Director at Calliditas Therapeutics Suisse SA; Director-Capital Markets at Zeltia SA from 2001 to 2007; Independent Director at Ablynx NV from 2013 to 2018; Independent Director at Zealand Pharma A from 2014 to 2019; Independent Director at ABIONYX Pharma SA from 2015 to 2018; Executive Director-Investment Banking at Salomon Smith Barney, Inc. from 1997 to 2000; Independent Director at Strategic Partners A from 2017 to 2021; Non-Executive Director at Kymab Ltd. from 2019 to 2021; Director at Creabilis SA; Director at Calliditas Therapeutics France SAS from 2017 to 2020; Director at Kymab Group Ltd.; Independent Non-Executive Director at Oxford Biomedica Plc from 2021 to 2024; Independent Non-Executive Director at Biotalys NV from 2021 to 2024; Member-Supervisory Board at Dr. Reddy's Research & Development BV in 2012; Executive Vice President-Finance & Strategy at Innate Pharma SA from 2011 to 2016; Chief Financial Officer at Movetis NV from 2008 to 2010; and Partner at STJ Advisors LLP from 2011 to 2013.
Education includes graduate and MBAistration degrees from Yale University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 117 944 ( 0,07 % ) | 421 060 $ | 31/05/2026 | |
OXFORD BIOMEDICA PLC 0,02 % | 31/12/2024 | 25 287 ( 0,02 % ) | 214 058 $ | 31/05/2026 |
| 01/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Catherine Moukheibir
| Sociétés | Poste | Début |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/04/2019 |
| MOONLAKE IMMUNOTHERAPEUTICS | Directeur/Membre du Conseil | 05/04/2022 |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Directeur/Membre du Conseil | - |
Noema Pharma AG
 Noema Pharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that provide therapeutics for central nervous system | Directeur/Membre du Conseil | 09/11/2021 |
DNA Script SAS
 DNA Script SAS Miscellaneous Commercial ServicesCommercial Services Engages in R&D, produce single-stranded DNA sequence nucleotide chemistries and microbiology consumables | Directeur/Membre du Conseil | 21/10/2021 |
Asceneuron SA
 Asceneuron SA BiotechnologyHealth Technology Develops therapeutics for neurodegenerative disorders | Directeur/Membre du Conseil | 16/07/2021 |
CMR Surgical Ltd.
 CMR Surgical Ltd. Medical SpecialtiesHealth Technology Manufactures surgical robotic systems for minimal access surgery | Directeur/Membre du Conseil | 21/01/2021 |
Esteve Healthcare SL
 Esteve Healthcare SL Pharmaceuticals: MajorHealth Technology Develops and manufactures molecules APIs & pharmaceutical intermediates | Directeur/Membre du Conseil | - |
Anciens postes connus de Catherine Moukheibir
| Sociétés | Poste | Fin |
|---|---|---|
| BIOTALYS NV | Directeur/Membre du Conseil | 25/09/2024 |
| ░░░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Catherine Moukheibir
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
30
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 30 |
|---|---|
Morgan Stanley
 Morgan Stanley Investment ManagersFinance Provides wealth and asset management, trading & investment banking services | Finance |
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
Zeltia SA
 Zeltia SA BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Develops injectable formulations and drugs | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innate Pharma SA
 Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
ABIONYX Pharma SA
 ABIONYX Pharma SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel HDL therapies for the treatment of cardiovascular and metabolic diseases | Health Technology |
Movetis NV
 Movetis NV Pharmaceuticals: GenericHealth Technology Specializes in developing compounds for gastrointestinal disorders | Health Technology |
Creabilis Therapeutics Srl
 Creabilis Therapeutics Srl Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Salomon Smith Barney, Inc.
 Salomon Smith Barney, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Strategic Partners A/S
 Strategic Partners A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic treatment of of diseases caused by defects in the function and metabolism of proteins | Health Technology |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
Creabilis Holdings Ltd.
 Creabilis Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
STJ Advisors LLP
 STJ Advisors LLP Investment ManagersFinance Provides capital markets advisory services | Finance |
Biotalys NV
 Biotalys NV Chemicals: AgriculturalProcess Industries Develops sustainable crop protection products | Process Industries |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology Operates as a biotechnology company developing new drugs for nervous system disorders | Health Technology |
Asceneuron SA
Asceneuron SA BiotechnologyHealth Technology Develops therapeutics for neurodegenerative disorders | Health Technology |
CMR Surgical Ltd.
CMR Surgical Ltd. Medical SpecialtiesHealth Technology Manufactures surgical robotic systems for minimal access surgery | Health Technology |
Creabilis SA | |
Calliditas Therapeutics France SAS
 Calliditas Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Engages in biotechnology research and development | Commercial Services |
DNA Script SAS
DNA Script SAS Miscellaneous Commercial ServicesCommercial Services Engages in R&D, produce single-stranded DNA sequence nucleotide chemistries and microbiology consumables | Commercial Services |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Health Technology |
Noema Pharma AG
Noema Pharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that provide therapeutics for central nervous system | Commercial Services |
Esteve Healthcare SL
Esteve Healthcare SL Pharmaceuticals: MajorHealth Technology Develops and manufactures molecules APIs & pharmaceutical intermediates | Health Technology |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
MoonLake Immunotherapeutics
 MoonLake Immunotherapeutics Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
